Trial · NCT06208956
A Low Dose Dexmedetomidine in Sedation Colonoscopy
NCT06208956, Not applicable, Unknown, West China Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Low Dose Dexmedetomidine in Sedation Colonoscopy. Trials, record NCT06208956. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06208956
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Low Dose Dexmedetomidine in Sedation Colonoscopy
- NCT number
- NCT06208956
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 104 participants, estimated
- Lead sponsor
- West China Hospital
- Conditions
- Colonoscopy
- Interventions
- Dexmedetomidine, Propofol
- First posted
- 2024-01-17
- Last updated
- 2024-01-17
Source ClinicalTrials.gov
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The primary outcome is the incidence of hypotension | The time during colonoscopy, an average of 15 minutes | Hypotension is defined as 20% decrease from baseline systolic blood pressure (SBP) or diastolic blood pressure (DBP), or SBP \< 90, and/or DBP \< 50 mmHg |
| Secondary | Area under the threshold (AUT) of hypotension | The time during colonoscopy, an average of 15 minutes | AUT=depth of hypotension below (a 20% decrease in baseline SBP or DBP) or (90 mm Hg of SBP or 50 mm Hg of DBP)× time in minutes spent of hypotension. As an example, a patient undergoes colonoscopy that lasts 15 min, in which he experiences 2 episodes of hypotension, all lasting for 1 min and all with a minimal SBP of 80 mm Hg. The AUT = 2 min × (90 -80= 10 mm Hg under the SBP threshold of 90 mm Hg) = 2×10 = 20 mm Hg per minute. |
| Secondary | Time-weighted average (TWA) | The time during colonoscopy, an average of 15 minutes | TWA is calculated as the AUT divided by the total duration of colonoscopy |
| Secondary | Cumulative duration of hypotension | The time during colonoscopy, an average of 15 minutes | The total time of patients experience hypotenion（hpotension defined as 20% decrease from baseline systolic blood pressure (SBP) or diastolic blood pressure (DBP), or SBP \< 90, and/or DBP \< 50 mmHg) |
| Secondary | Maximum reduction in blood pressure (BP) | The time during colonoscopy, an average of 15 minutes | Maximum reduction in systolic blood pressure (SBP) ,diastolic blood pressure (DBP) and mean arterial pressure (MAP) from baseline |
| Secondary | The incidence of bradycardia | The time during colonoscopy, an average of 15 minutes | Bradycardia is defined as heat rate(HR) \<50 beats/min |
| Secondary | The incidence of hypoxemia | The time during colonoscopy, an average of 15 minutes | Hypoxemia is defined as oxygen saturation (SpO2)\<90% |
| Secondary | The body movement | The time during colonoscopy, an average of 15 minutes | The twisting of the patient's body due to the stimulation of the colonoscopy, making it difficult to proceed with the procedure |
| Secondary | Discharge time | From the end of colonoscopy to discharge，an average of 40 minutes | From the end of colonoscopy to discharge |
| Secondary | Patients satisfaction score | When the patient is fully awake after colonoscopy，an average of 5 minutes | Using an 11-point Likert scale, with 0 indicating "very dissatisfied" and 10 indicating "very satisfied" |
1 to 10 of 14Source ClinicalTrials.gov
See all 14 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06208956
GET https://conductscience.org/api/trials/v1/NCT06208956/registered